Sutro Biopharma Stock (NASDAQ: STRO) stock price, news, charts, stock research, profile.
Open | $3.720 |
Close | $3.470 |
Volume / Avg. | 731.249K / 997.859K |
Day Range | 3.400 - 3.750 |
52 Wk Range | 2.005 - 6.130 |
Market Cap | $273.069M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 3.16% |
Days to Cover | 1.64 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Sutro Biopharma (NASDAQ: STRO) through any online brokerage.
Other companies in Sutro Biopharma’s space includes: Renovaro (NASDAQ:RENB), Inozyme Pharma (NASDAQ:INZY), Inovio Pharmaceuticals (NASDAQ:INO), Adaptimmune Therapeutics (NASDAQ:ADAP) and Tevogen Bio Holdings (NASDAQ:TVGN).
The latest price target for Sutro Biopharma (NASDAQ: STRO) was reported by Piper Sandler on Wednesday, April 3, 2024. The analyst firm set a price target for 11.00 expecting STRO to rise to within 12 months (a possible 209.86% upside). 22 analyst firms have reported ratings in the last year.
The stock price for Sutro Biopharma (NASDAQ: STRO) is $3.55 last updated April 24, 2024 at 7:51 PM EDT.
There are no upcoming dividends for Sutro Biopharma.
Sutro Biopharma’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Sutro Biopharma.
Sutro Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.